These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 9134967)

  • 21. Effect of PT-treatment on ANP-mediated inhibition of adenylate cyclase and amylase release in rat parotid gland.
    Shimomura H; Nashida T; Imai A
    Mol Cell Biochem; 1994 Oct; 139(1):53-8. PubMed ID: 7531819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vip-induced cross-talk between G-proteins in membranes from rat anterior pituitary cells.
    Cussac D; Kordon C; Enjalbert A; Saltarelli D
    Cell Signal; 1993 Mar; 5(2):119-37. PubMed ID: 8499223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures.
    Patrizio M; Colucci M; Levi G
    J Neurochem; 2001 Apr; 77(2):399-407. PubMed ID: 11299302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies.
    Sheriff S; Balasubramaniam A
    J Biol Chem; 1992 Mar; 267(7):4680-5. PubMed ID: 1537851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
    Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
    Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.
    Schoepp DD; Salhoff CR; Wright RA; Johnson BG; Burnett JP; Mayne NG; Belagaje R; Wu S; Monn JA
    Neuropharmacology; 1996; 35(12):1661-72. PubMed ID: 9076745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of NMDA receptor-mediated transmission in turtle cerebellar granule cells by activation of metabotropic glutamate receptors.
    Kinney GA; Slater NT
    J Neurophysiol; 1993 Feb; 69(2):585-94. PubMed ID: 7681476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.
    Akam EC; Carruthers AM; Nahorski SR; Challiss RA
    Br J Pharmacol; 1997 Jul; 121(6):1203-9. PubMed ID: 9249258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of inhibitory GTP binding regulatory protein in alpha 2-adrenoceptor-mediated inhibition of adenylate cyclase activity in cerebral cortical membranes of rats.
    Kitamura Y; Nomura Y; Segawa T
    J Neurochem; 1985 Nov; 45(5):1504-8. PubMed ID: 2995588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E receptors in bovine adrenal medulla are coupled to adenylate cyclase via Gi and to phosphoinositide metabolism in a pertussis toxin-insensitive manner.
    Negishi M; Ito S; Hayaishi O
    J Biol Chem; 1989 Mar; 264(7):3916-23. PubMed ID: 2537296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (1 S,3 R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in the neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide- and inhibitory cyclic AMP-coupled mGluRs.
    Schoepp DD; Johnson BG; Monn JA
    J Neurochem; 1996 May; 66(5):1981-5. PubMed ID: 8780026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of T-588, a novel cognitive enhancer, on ADP-ribosylation of G(s alpha) by cholera toxin and cyclic AMP accumulation in rat cerebral cortex.
    Maekawa M; Miyazaki H; Ono S; Narita H; Murayama T; Nomura Y
    Neurochem Int; 1999 Feb; 34(2):149-55. PubMed ID: 10213074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships for a series of phenylglycine derivatives acting at metabotropic glutamate receptors (mGluRs).
    Bedingfield JS; Kemp MC; Jane DE; Tse HW; Roberts PJ; Watkins JC
    Br J Pharmacol; 1995 Dec; 116(8):3323-9. PubMed ID: 8719814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulatory effects of NMDA on phosphoinositide responses evoked by the metabotropic glutamate receptor agonist 1S,3R-ACPD in neonatal rat cerebral cortex.
    Challiss RA; Mistry R; Gray DW; Nahorski SR
    Br J Pharmacol; 1994 May; 112(1):231-9. PubMed ID: 7913380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells.
    Chavis P; Shinozaki H; Bockaert J; Fagni L
    J Neurosci; 1994 Nov; 14(11 Pt 2):7067-76. PubMed ID: 7965099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine.
    Winder DG; Conn PJ
    J Neurosci; 1993 Jan; 13(1):38-44. PubMed ID: 8380851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit.
    Walseth TF; Zhang HJ; Olson LK; Schroeder WA; Robertson RP
    J Biol Chem; 1989 Dec; 264(35):21106-11. PubMed ID: 2556393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabotropic glutamate receptor agonists potentiate cyclic AMP formation induced by forskolin or beta-adrenergic receptor activation in cerebral cortical astrocytes in culture.
    Balázs R; Miller S; Chun Y; O'Toole J; Cotman CW
    J Neurochem; 1998 Jun; 70(6):2446-58. PubMed ID: 9603209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between metabotropic receptors and purinergic transmission in rat hippocampal slices.
    Casabona G; L'Episcopo MR; Di Iorio P; Ciccarelli R; De Bernardis E; Shinozaki H; Nicoletti F; Caciagli F
    Brain Res; 1994 May; 645(1-2):13-8. PubMed ID: 8062075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and models for estimating antagonist potency (pA2, Kd and IC50) following the detection of antagonism observed in the presence of intrinsic activity.
    Ghosh K; Kowal D; Dawson LA; Tasse R
    Neuropharmacology; 1999 Mar; 38(3):361-73. PubMed ID: 10219974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.